---
layout: minimal-medicine
title: Vorapaxar
---

# Vorapaxar
### Generic Name
Vorapaxar

### Usage
Vorapaxar is an antiplatelet medication primarily used to reduce the risk of thrombotic cardiovascular events in patients with a history of myocardial infarction (heart attack) or peripheral arterial disease (PAD).  These events include cardiovascular death, myocardial infarction (another heart attack), stroke, and the need for urgent coronary revascularization (procedures to restore blood flow to the heart).  It's important to note that Vorapaxar is not typically used alone; it's generally administered in conjunction with aspirin and/or clopidogrel, other medications that prevent blood clots. The overall clinical benefit of adding vorapaxar to existing antiplatelet therapy remains a subject of ongoing evaluation, with a need to carefully weigh the risk of bleeding against the potential reduction in cardiovascular events.

### Dosage
The typical adult dose of vorapaxar is 2.08 mg once daily (OD).  This is equivalent to 2.5 mg of vorapaxar sulfate.  It's crucial to understand that this medication is usually taken in combination with aspirin and/or clopidogrel, as determined by a physician.  There is limited experience with vorapaxar as a monotherapy or with antiplatelet agents other than aspirin and/or clopidogrel. The safety and effectiveness of vorapaxar in children have not been established. Dosage adjustments for those with hepatic (liver) or renal (kidney) impairment may be necessary.  Mild to moderate hepatic impairment does not typically require dosage changes, but it's not recommended for those with severe hepatic impairment. Renal impairment usually doesn't necessitate dosage alterations.  However, it's essential to consult a healthcare provider for individualized dosage recommendations based on the patient's specific condition and other health factors.

### Side Effects
Common side effects may include:

*   Hemorrhage (major bleeding, potentially life-threatening) - This is a significant risk associated with vorapaxar and is particularly concerning given its prolonged effects.
*   Depression
*   Gastrointestinal hemorrhage
*   Skin rash
*   Iron deficiency
*   Anemia

Less common, but serious side effects include intracranial hemorrhage (bleeding in the brain), diplopia (double vision), or other oculomotor disturbances (problems with eye movement).  Any significant or concerning side effects should be reported immediately to a healthcare professional.


### How it Works
Vorapaxar works by blocking the protease-activated receptor-1 (PAR-1) on platelets.  Platelets are blood cells essential for blood clotting.  By inhibiting PAR-1, vorapaxar reduces platelet aggregation (clumping together), thus lessening the likelihood of thrombus (blood clot) formation.  The effect of vorapaxar is long-lasting due to its prolonged half-life, meaning that its effect on platelets persists even after discontinuation of the medication, for up to four weeks.

### Precautions
Several significant precautions should be considered when using vorapaxar:

*   **Contraindications:** Vorapaxar should not be used in individuals with a history of stroke, transient ischemic attack (TIA), or intracranial hemorrhage; active pathological bleeding (such as from a peptic ulcer); or hypersensitivity to vorapaxar or any components of the formulation.  Individuals with severe hepatic impairment should also avoid using this medication.

*   **Increased Bleeding Risk:** Vorapaxar significantly increases the risk of bleeding, including potentially life-threatening intracranial hemorrhage.  Close monitoring for bleeding is crucial.

*   **Drug Interactions:**  Concurrent use with strong CYP3A inhibitors (e.g., ketoconazole, itraconazole) or inducers (e.g., rifampin) should be avoided, as these can significantly affect vorapaxar's blood levels.

*   **Pregnancy and Breastfeeding:**  Vorapaxar is a Category B drug during pregnancy, meaning animal studies have not shown risk to the fetus, but controlled human studies are lacking. Due to the potential for serious adverse events like maternal bleeding and its long half-life, alternative agents might be preferable during pregnancy.  It's not recommended to breastfeed while taking vorapaxar.

*   **Geriatric Patients and Patients with Hepatic/Renal Impairment:**  Use caution in elderly patients and those with mild to moderate hepatic or renal impairment.

### FAQs
*   **Q: Can I take vorapaxar with other medications?**  A:  It's crucial to discuss all medications (including over-the-counter drugs and herbal supplements) with your doctor before starting vorapaxar, as interactions can occur.

*   **Q: How should I store vorapaxar?**  A: Store as directed by your pharmacist or healthcare provider.

*   **Q: What should I do if I miss a dose?**  A:  Do not take a double dose; consult your doctor or pharmacist for guidance.

*   **Q: Can I stop taking vorapaxar suddenly?**  A:  No, discontinuation should be done gradually under medical supervision.

*   **Q:  What are the most serious risks associated with vorapaxar?** A: The most significant risk is increased bleeding, particularly major or life-threatening hemorrhage, including intracranial hemorrhage.

**Disclaimer:** This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting or stopping any medication.
